QRSL1
protein-codingglutaminyl-tRNA amidotransferase subunit QRSL1, the group of Glutamyl-tRNA amidotransferase subunits
Gene summary
Contributes to glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity. Involved in glutaminyl-tRNAGln biosynthesis via transamidation and mitochondrial translation. Located in mitochondrion. Part of glutamyl-tRNA(Gln) amidotransferase complex. Implicated in combined oxidative phosphorylation deficiency 40. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~38.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0030006
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0030006
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0030006
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Biochemical; Cardiovascular; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to QRSL1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018292.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 38 | 2 | 42 | ||
| missense | 2 | 2 | 77 | 9 | 90 | |
| nonsense | 2 | 2 | 4 | |||
| start loss | 0 | |||||
| frameshift | 3 | 2 | 1 | 6 | ||
| splice donor/acceptor (+/-2bp) | 1 | 4 | 5 | |||
| Total | 7 | 5 | 86 | 47 | 2 | 147 |
Highest pathogenic variant AF is 0.000031818534
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060762.3 | 11 | MANE Select | |
| Ensembl | ENSP00000358042.4 | 11 | MANE Select | |
| Ensembl | ENSP00000358040.1 | 7 | Standard | |
| Ensembl | ENSP00000358040.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Aminoacyl-tRNA biosynthesis - Homo sapiens (human)
- L-glutamine tRNA biosynthesis
Biological Process
- regulation of protein stability
- mitochondrial translation
- glutaminyl-tRNAGln biosynthesis via transamidation
Molecular Function
- amidase activity
- protein binding
- ATP binding
- glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity
Cellular Component
- mitochondrion
- glutamyl-tRNA(Gln) amidotransferase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000369046
- Coding exons
- 11
- Length
- 38840
- Individuals with no LoFs
- 125692
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 56
- Defined
- 125748
- p
- 0.000223
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.07 | 228 | 278 | 0.819 | 0.0000134 | 3410 |
| Missense (PolyPhen) | 67 | 109.81 | 0.61014 | 1388 | ||
| Synonymous | -0.586 | 111 | 103 | 1.07 | 0.00000519 | 1043 |
| Loss of Function | 1.99 | 16 | 27.2 | 0.588 | 0.00000143 | 338 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00018 | 0.00018 | rare |
| Latino/Admixed American | 0.00029 | 0.00029 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.000092 | 0.000092 | rare |
| European (Non-Finnish) | 0.00019 | 0.00019 | rare |
| South Asian | 0.00039 | 0.00039 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Allows the formation of correctly charged Gln-tRNA(Gln) through the transamidation of misacylated Glu-tRNA(Gln) in the mitochondria. The reaction takes place in the presence of glutamine and ATP through an activated gamma-phospho-Glu- tRNA(Gln). {ECO:0000255|HAMAP-Rule:MF_03150, ECO:0000269|PubMed:19805282}.;
- Disease
- DISEASE: Note=Defects in QRSL1 may play a role in mitochondrial disorders characterized by combined respiratory chain complex deficiencies. {ECO:0000269|PubMed:26741492}.;
Recessive Scores
- pRec
- 0.193
Intolerance Scores
- LoFtool
- 0.797
- RVIS EVS
- 0.42
- RVIS percentile EVS
- 77.16
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- N
- Indispensability score
- 0.483
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |